Cross tolerance between d-2-brom-lysergic acid diethylamide (BOL-148) and the d-diethylamide of lysergic acid (LSD-25)

@article{Isbell2004CrossTB,
  title={Cross tolerance between d-2-brom-lysergic acid diethylamide (BOL-148) and the d-diethylamide of lysergic acid (LSD-25)},
  author={Harris Isbell and Edward J. Miner and C. R. Logan},
  journal={Psychopharmacologia},
  year={2004},
  volume={1},
  pages={109-116}
}
Summary1.Simultaneous administration of 2 to 4 mg of d-2-Brom lysergic acid diethylamide (BOL-148) did not reduce the intensity of the reaction caused by 0.5 to 1.5mcg/kg of LSD-25.2.Pre-treatment of 8 subjects with 3 mg of BOL-148 daily for two days caused statistically nonsignificant reductions in all aspects of the reaction induced by 1 mcg/kg of LSD-25.3.Pre-treatment of 10 subjects with 3 mg of BOL-148 for five days resulted in statistically significant attenuation of all aspects of the… 
Tolerance and Cross-Tolerance to Head Twitch Behavior Elicited by Phenethylamine- and Tryptamine-Derived Hallucinogens in Mice
TLDR
The use of phenethylamine-derived hallucinogens as therapeutic agents may be limited not only by their abuse potential, but also by the rapid development of tolerance that would likely be maintained even if a patient were switched to a different 5-HT2A agonist medication from a distinct structural class.
Tolerance and cross-tolerance among psychotomimetic drugs
TLDR
A decrease in the amount of disruption of bar-pressing occurs with repeated daily administration of appropriate doses of all of the “psychotomimetic” compounds, and cross-tolerance was also demonstrated.
Cross tolerance to tryptamine in the LSD tolerant dog
TLDR
Observations support the concept that tryptamines and LSD have a common mode of action and the hypothesis that LSD exerts some of its pharmacologic effects by acting as an agonist at tryptamine receptors.
A neuropharmacological investigation on hallucinogenic drugs. Laboratory results versus clinical trials
TLDR
Comparison of pharmacological and clinical data shows a poor correlation with biochemical results, while exhibiting good correlation with the electroencephalographic and behavioural results.
The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines
TLDR
Preliminary evidence is obtained supporting that the similarity between the binding affinity profiles of psychoactive substituted phenethylamines and tryptamines is correlated with the semantic similarity of the associated reports.
The behavioral pharmacology of hallucinogens.
TLDR
The behavioral pharmacology of phenethylamine, tryptamine, and ergoline hallucinogens are described in this review, paying particular attention to important structure activity relationships which have emerged, receptors involved in their various actions, effects on conditioned and unconditioned behaviors, and in some cases, human psychopharmacology.
Psychedelics
TLDR
Blood oxygen level–dependent functional magnetic resonance imaging and magnetoencephalography have been employed for in vivo brain imaging in humans after administration of a psychedelic, and results indicate that intravenously administered psilocybin and LSD produce decreases in oscillatory power in areas of the brain’s default mode network.
Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans
TLDR
The non‐clinical tests required for a regulatory evaluation of abuse/dependence risks, i.e., drug‐discrimination, intravenous self‐administration and physical dependence liability, are described and views on how these non-clinical tests can be refined to provide more meaningful information to aid the assessment of the risks posed by CNS drug‐candidates for abuse andPhysical dependence are offered.
Chronic pain and psychedelics: a review and proposed mechanism of action
TLDR
The alterations in FC seen with psychedelic use suggest a way that these agents could help reverse the changes in neural connections seen in chronic pain states, which is time to consider further research on psychedelics as analgesics in order to improve the lives of patients with chronic pain conditions.
Assessment of Potential Long Term Health Effects on Army Human Test Subjects of Relevant Biological and Chemical Agents, Drugs, Medications and Substances
Abstract : Between 1954 and 1975, more than 12,000 men entering or in military service in the United States (US) served as medical research volunteers for the countrys biological and chemical warfare
...
1
2
...

References

SHOWING 1-10 OF 12 REFERENCES
Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
TLDR
It will be shown on the basis of the data that 1-methyl-d-lysergic acid diethylamide (MLD-41) affects both the Siamese fighting fish and man in a manner similar to LSD-25, however, there are important differences; in the fish it is about 1/10 as effective as LSD- 25, whereas it is approximately 1/3 as effective in man.
Prevention of Psychological Effects of d-Lysergic Acid Diethylamide (LSD 25) by its 2-Brom Derivative (BOL 148)
TLDR
The 2-brom derivative of LSD 25 (BOL 148) exerts no psychological effects, and the D-lysergic acid diethylamide derivative (LSD 25) could be influenced by one of its psychologically inactive derivatives.
Comparative subjective effects of seven drugs including lysergic acid diethylamide (LSD-25).
TLDR
Although differentiation between 3 lysergic acid derivatives, Ergonovine, LAE-32, and BOL-148, and between alcohol, methamphetamine, and scopolamine was not clear cut, the number of responses to the questionnaire under these drugs was clearly greater than those given under water.
Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.
TLDR
The striking mental changes induced by the diethylamide of lysergic acid (hereafter referred to as LSD) have been studied extensively in Europe, Great Britain and the United States and are apparently the most effective and safest agent for inducing an experimental, but reversible, psychosis in nonpsychotic subjects.
Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25)
TLDR
The data do not support but do not disprove the “serotonin deficiency” hypothesis of the LSD psychosis, and high potency as a serotonin antagonist in isolated smooth muscle preparations was not correlated with high potency in man as a psychotomimetic.
Role of 5-Hydroxytryptamine in Mental Diseases and its Antagonism to Lysergic Acid Derivatives
TLDR
The hypothesis is that certain of the actions of 5-hydroxytryptamine are antagonized by lysergic acid diethylamide, a drug which on oral application and in doses of only 0.5–1.0 µgm./kgm produces pronounced psychic disturbances in normal human beings.
Studies on heptazone (6-morpholino-4,4-diphenyl-3-heptanone hydrochloride) in comparison with other analgesic drugs.
TLDR
Cross-tolerance studies showed that methadone was able to break through a tolerance to morphine or Heptazone, and dogs rendered only moderately tolerant to Methadone were more tolerant to the other drugs used than to methamphetamineadone itself.
LYSERGIC ACID DIETHYLAMIDE AND RELATED SUBSTANCES
  • E. Rothlin
  • Biology, Medicine
    Annals of the New York Academy of Sciences
  • 1957
TLDR
The object here is to furnish an account of the pharmacological characteristics of LSD and some of its related compounds.
SOME RAPID APPROXIMATE STATISTICAL PROCEDURES
The last twenty years have seen a great increase in the use of statistical methods in various branches of science and technology. One of the obstacles to the more widespread use of these methods is
...
1
2
...